WebNov 18, 2024 · NovaBay Pharmaceuticals, Inc. announced that it has received $3.25 million in funding 11/18/2024 EDT On November 18, 2024, NovaBay Pharmaceuticals, Inc. closed the transaction. The company has received $1,184,500 in its final tranche. The company has issued 3,250 shares of the series C preferred stock for gross proceeds of $3,250,000. WebMar 30, 2024 · NovaBay Pharmaceuticals, Inc. gab die Ergebnisse für das vierte Quartal und das am 31. Dezember 2024 endende Geschäftsjahr bekannt. Für das vierte Quartal …
NovaBay Pharmaceuticals, Inc. announced that it has received …
WebApr 25, 2024 · EMERYVILLE, Calif., April 25, 2024 -- ( BUSINESS WIRE )-- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter... WebMar 30, 2024 · NovaBay Pharmaceuticals Reports 2024 Fourth Quarter and Full Year Financial Results Business Wire March 30, 2024, 4:06 PM · 12 min read Product sales … fluid flow velocity calculator
NovaBay Pharmaceuticals, Inc
WebNov 5, 2024 · NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2024 and provides a business update. Financial results for 2024 include DERMAdoctor ®, which NovaBay acquired on November 5, 2024. http://markets.buffalonews.com/buffnews/article/bizwire-2024-3-30-novabay-pharmaceuticals-reports-2024-fourth-quarter-and-full-year-financial-results WebMar 29, 2024 · NovaBay Pharmaceuticals Inc (NBY) stock is trading at $1.62 as of 12:29 PM on Wednesday, Mar 29, a rise of $0.01, or 0.62% from the previous closing price of $1.61. The stock has traded between $1.61 and $1.74 so far today. Volume today is light. So far 7,156 shares have traded compared to average volume of 13,331 shares. greene treatment center carmichaels pa